Report #2845043

Overview

Sex

Unknown

Age

Age unknown

State

NC

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Late 2nd dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: Late 2nd dose.). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-JUN-2025 A pharmacist called to ask a question about Twinrix, she asked If a patient missed the mark for the 2nd dose of Twinrix and get it 3 months later, when to administer the 3rd dose which led to drug dose interval too long. Pharmacist mentioned that this scenario has happened in the past at their facility.